U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Lymphoblastic leukemia, acute, with lymphomatous features(LALL)

MedGen UID:
340879
Concept ID:
C1855472
Neoplastic Process
Synonyms: LALL; LYMPHOMATOUS ALL
 
Monarch Initiative: MONDO:0009539
OMIM®: 247640

Clinical features

From HPO
Acute lymphoid leukemia
MedGen UID:
7317
Concept ID:
C0023449
Neoplastic Process
Acute lymphoblastic leukemia (ALL), also known as acute lymphocytic leukemia, is a subtype of acute leukemia, a cancer of the white blood cells. Somatically acquired mutations in several genes have been identified in ALL lymphoblasts, cells in the early stages of differentiation. Germline variation in certain genes may also predispose to susceptibility to ALL (Trevino et al., 2009). Genetic Heterogeneity of Acute Lymphoblastic Leukemia A susceptibility locus for acute lymphoblastic leukemia (ALL1) has been mapped to chromosome 10q21. See also ALL2 (613067), which has been mapped to chromosome 7p12.2; and ALL3 (615545), which is caused by mutation in the PAX5 gene (167414) on chromosome 9p.
Lymphoma
MedGen UID:
44223
Concept ID:
C0024299
Neoplastic Process
A cancer originating in lymphocytes and presenting as a solid tumor of lymhpoid cells.
T-cell acute lymphoblastic leukemia
MedGen UID:
368378
Concept ID:
C1961099
Neoplastic Process
Acute lymphoblastic leukemia of T-cell origin. It comprises about 15% of childhood cases and 25% of adult cases. It is more common in males than females.

Recent clinical studies

Diagnosis

Ferguson D, Kovach AE
Blood 2018 Aug 9;132(6):673. doi: 10.1182/blood-2018-04-842724. PMID: 30093385

Therapy

Ferguson D, Kovach AE
Blood 2018 Aug 9;132(6):673. doi: 10.1182/blood-2018-04-842724. PMID: 30093385

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...